Eyenovia Inc. (NASDAQ: EYEN) stock closed at 1.84 per share at the end of the most recent trading day (a 1.1% change compared to the prior day closing price) with a volume of 134.27K shares and market capitalization of 61.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 29 people. Eyenovia Inc. CEO is Tsontcho Ianchulev.

The one-year performance of Eyenovia Inc. stock is -66.3%, while year-to-date (YTD) performance is -54%. EYEN stock has a five-year performance of %. Its 52-week range is between 1.61 and 6.63, which gives EYEN stock a 52-week price range ratio of 4.58%

Eyenovia Inc. currently has a PE ratio of -3.50, a price-to-book (PB) ratio of 2.05, a price-to-sale (PS) ratio of 5.15, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -42.78%, a ROC of -56.44% and a ROE of -70.43%. The company’s profit margin is -61.89%, its EBITDA margin is -116.50%, and its revenue ttm is $12.00 Million , which makes it $0.36 revenue per share.

Of the last four earnings reports from Eyenovia Inc., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. Eyenovia Inc.’s next earnings report date is 10th Aug 2022.

The consensus rating of Wall Street analysts for Eyenovia Inc. is Strong Buy (1), with a target price of $14, which is +660.87% compared to the current price. The earnings rating for Eyenovia Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eyenovia Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eyenovia Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.13, ATR14 : 0.19, CCI20 : -70.66, Chaikin Money Flow : -0.31, MACD : -0.14, Money Flow Index : 38.97, ROC : -16.13, RSI : 37.67, STOCH (14,3) : 29.17, STOCH RSI : 1.00, UO : 30.59, Williams %R : -70.83), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eyenovia Inc. in the last 12-months were: Charles E. Mather (Buy at a value of $42 006), Kenneth B. Lee (Buy at a value of $22 000), Michael M. Rowe (Buy at a value of $11 568), Stuart M. Grant (Buy at a value of $425 750), Tsontcho Ianchulev (Buy at a value of $121 206)